Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung CancerJames Chih‐Hsin Yang, Gongyan Chen, Filippo de Marinis et al.|Journal of Clinical Oncology|2024Cited by 137
Learning From Imbalanced Data Using Triplet Adversarial SamplesJaesub Yun, Jong‐Seok Lee|IEEE Access|2023Cited by 1